These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2244 related articles for article (PubMed ID: 1935537)

  • 61. Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study.
    D'Amico F; Gomollón F; Bamias G; Magro F; Targownik L; Leitner C; Heatta-Speicher T; Michelena N; Kolterer S; Lapthorn J; Kauffman L; Dignass A;
    United European Gastroenterol J; 2024 Jul; 12(6):705-716. PubMed ID: 38733307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inflammatory bowel disease.
    Gibson PR; Anderson RP
    Med J Aust; 1998 Oct; 169(7):387-94. PubMed ID: 9803254
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.
    Massuger W; Moore GTC; Andrews JM; Kilkenny MF; Reyneke M; Knowles S; Purcell L; Alex G; Buckton S; Page AT; Stocks N; Cameron D; Manglaviti F; Pavli P
    Intern Med J; 2019 Jul; 49(7):859-866. PubMed ID: 30525299
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study.
    Carpio D; Barreiro-de Acosta M; Echarri A; Pereira S; Castro J; Ferreiro R; Lorenzo A;
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1030-7. PubMed ID: 26049704
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnosis and management of inflammatory bowel disease in children.
    Carvalho R; Hyams JS
    Semin Pediatr Surg; 2007 Aug; 16(3):164-71. PubMed ID: 17602971
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Update in pediatric inflammatory bowel disease.
    Rabizadeh S; Dubinsky M
    Rheum Dis Clin North Am; 2013 Nov; 39(4):789-99. PubMed ID: 24182855
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diet therapy for inflammatory bowel diseases: The established and the new.
    Durchschein F; Petritsch W; Hammer HF
    World J Gastroenterol; 2016 Feb; 22(7):2179-94. PubMed ID: 26900283
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy.
    Kiernan MG; Coffey JC; Sahebally SM; Tibbitts P; Lyons EM; O'leary E; Owolabi F; Dunne CP
    J Crohns Colitis; 2020 Jan; 14(1):118-129. PubMed ID: 31241755
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.
    Lashner BA; Shaheen NJ; Hanauer SB; Kirschner BS
    Am J Gastroenterol; 1993 Mar; 88(3):356-9. PubMed ID: 8438840
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.
    Greuter T; Porchet F; Braga-Neto MB; Rossel JB; Biedermann L; Schreiner P; Scharl M; Schoepfer AM; Safroneeva E; Straumann A; Rogler G; Vavricka SR
    United European Gastroenterol J; 2020 Dec; 8(10):1196-1207. PubMed ID: 33276710
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease.
    López-Vivancos J; Casellas F; Badia X; Vilaseca J; Malagelada JR
    Digestion; 1999; 60(3):274-80. PubMed ID: 10343142
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.
    Clarke K; Chintanaboina J
    Clin Rev Allergy Immunol; 2019 Oct; 57(2):179-193. PubMed ID: 29754190
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Inflammatory bowel disease].
    Patuto N; Beglinger C
    Praxis (Bern 1994); 2013 Aug; 102(17):1046-52. PubMed ID: 23965717
    [TBL] [Abstract][Full Text] [Related]  

  • 76. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 77. European Crohn's and Colitis Organisation Topical Review on Environmental Factors in IBD.
    Maaser C; Langholz E; Gordon H; Burisch J; Ellul P; Ramirez VH; Karakan T; Katsanos KH; Krustins E; Levine A; Mantzaris GJ; O'Morain C; Strid H; Yuksel ES; Annese V
    J Crohns Colitis; 2017 Aug; 11(8):905-920. PubMed ID: 28039310
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Recent progress in diagnosis and treatment of digestive diseases. III. Inflammatory bowel diseases. 7. Medical treatment of ulcerative colitis and Crohn's disease].
    Inoue M
    Nihon Naika Gakkai Zasshi; 1988 Nov; 77(11):1666-70. PubMed ID: 2907910
    [No Abstract]   [Full Text] [Related]  

  • 79. Drug therapy for inflammatory bowel disease: Part II.
    Linn FV; Peppercorn MA
    Am J Surg; 1992 Aug; 164(2):178-85. PubMed ID: 1636900
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland.
    Schoepfer A; Vavricka SR; Brüngger B; Blozik E; Bähler C
    Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):350-357. PubMed ID: 31834046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 113.